Decades of vaccination and prevention efforts may have the hepatitis viruses on the run, according to a new report from the U.S. Centers for Disease Control and Prevention released March 10.

Hepatits B

About one in five babies born to mothers with hepatitis B aren't getting treatments that have been shown to prevent the infection in newborns, a study whose findings were released online March 8 in advance of the April print issue of Pediatrics.

Hepetitis B

AltraVax Inc. has acquired a vaccine development technology package that gives AltraVax an exclusive license to develop vaccines for infectious diseases and is targeting influenza, a treatment for hepatitis B and HIV.

Hepetitis B

BERKELEY, Calif. — Dynavax Technologies Corp. will start a 2,000-patient trial of its investigational adult hepatitis B vaccine, aiming for data in the first half of 2011, the San Francisco Business Times reported Feb. 8.

Hepatitis B

A Scottish life science firm has secured an additional $3.1 million in funding to develop new vaccines, BBC News reported.

Hepatitis B

NEW YORK — Our expanding waistlines may have outgrown doctors’ needles, researchers report in the March issue of Pediatrics.

Hepatitis B

Dynavax Technologies Corp. announced Jan. 12 the addition of two new senior executives to direct key commercial and clinical activities prior to the launch of Heplisav, an investigational adult hepatitis B vaccine.

Hepatitis B

WASHINGTON — Stepped-up vaccination requirements, a boost in resources for prevention and treatment, and a public awareness campaign are needed to curb the health threats posed by hepatitis B and hepatitis C.

World Health Organization

AMSTERDAM — Dutch biotech firm Crucell NV will likely look to add a sixth antigen to its portfolio of childhood vaccines as part of expected product add-ons after a stake sale to Johnson & Johnson, Reuters reported Dec. 15.

Hepatitis E

KAABONG, Uganda — An outbreak of Hepatitis E has killed 12 people out of 210 infected in Uganda’s northeastern region of Karamoja, The New Vision Web site reported, citing Michael Lochiyo, the health educator of Kaabong district in the region.

Hepatitis B

Dynavax Technologies Corp. announced Dec. 9 that its manufacturing facility in Dusseldorf, Germany, has been approved for the commercial production of hepatitis B surface antigen.

J. Joseph Kim

SAN DIEGO — Inovio Biomedical Corp. announced Nov. 30 that its partner Tripep AB of Sweden has completed its phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine delivered using Inovio's electroporation technology.

HANOI, Vietnam — Through its commitment to immunization and other child health interventions, Vietnam has drastically reduced its child deaths, the GAVI Alliance announced Nov. 20 during its partner forum.

Pentavalent Vaccine

HANOI, Vietnam — Following the increasing impact of the GAVI Alliance on the vaccine market, the price of one of the major combination vaccines, the pentavalent, is falling considerably.

Fuad El-Hibri

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced that it has completed the acquisition of a 55,000-square-foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the city of Baltimore.

Dr. Michael Gale Jr.

SEATTLE— Kineta Inc. has announced that it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases to develop novel vaccine adjuvants (agents that help boost the immune system).

Fuad El-Hibri

GAITHERSBURG, Md. — Emergent BioSolutions announced that it acquired England-based Microscience Ltd., a privately held vaccine company primarily involved in the research and development of proprietary vaccines and immunotherapeutics.